IRIS
ALBISINNI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.806
AS - Asia 3.059
EU - Europa 2.136
SA - Sud America 552
AF - Africa 58
OC - Oceania 5
Totale 9.616
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.714
SG - Singapore 1.368
IT - Italia 1.013
HK - Hong Kong 486
BR - Brasile 458
CN - Cina 403
RU - Federazione Russa 362
VN - Vietnam 215
BD - Bangladesh 209
IE - Irlanda 189
JP - Giappone 174
NL - Olanda 170
DE - Germania 98
GB - Regno Unito 92
IN - India 48
FR - Francia 44
CA - Canada 38
AR - Argentina 36
MX - Messico 30
AT - Austria 27
TR - Turchia 27
PL - Polonia 24
ZA - Sudafrica 24
FI - Finlandia 22
UA - Ucraina 20
IQ - Iraq 19
EC - Ecuador 18
ID - Indonesia 18
IR - Iran 18
ES - Italia 17
BE - Belgio 13
PK - Pakistan 12
SE - Svezia 11
CL - Cile 10
MY - Malesia 10
KE - Kenya 8
KR - Corea 8
VE - Venezuela 8
CR - Costa Rica 7
PY - Paraguay 7
TN - Tunisia 7
IL - Israele 6
PE - Perù 6
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
HN - Honduras 4
PH - Filippine 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CO - Colombia 3
GR - Grecia 3
KZ - Kazakistan 3
MA - Marocco 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
SC - Seychelles 3
UZ - Uzbekistan 3
AL - Albania 2
AO - Angola 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GE - Georgia 2
JM - Giamaica 2
LT - Lituania 2
LU - Lussemburgo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
TZ - Tanzania 2
BB - Barbados 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 9.616
Salva come PNG Salva come JPEG
Città #
Singapore 707
San Jose 541
Hong Kong 480
Ashburn 280
Woodbridge 234
Wilmington 216
Houston 193
Dublin 188
Beijing 184
Center 176
New York 176
Tokyo 167
Council Bluffs 139
Santa Clara 110
The Dalles 104
Los Angeles 91
Milan 88
Ho Chi Minh City 85
St. George 85
Rome 84
Buffalo 80
Moscow 53
São Paulo 51
Redondo Beach 49
Hanoi 42
Chicago 39
London 36
Florence 29
Nuremberg 28
Seattle 25
North Bergen 23
Naples 22
Warsaw 21
Brooklyn 20
Turin 20
Atlanta 19
Genoa 18
Lauterbourg 18
Tehran 17
Zhengzhou 17
Dallas 16
Mexico City 16
Salt Lake City 16
Mülheim 15
Johannesburg 14
Rio de Janeiro 14
Denver 13
Frankfurt am Main 13
Boston 12
Chennai 12
Elk Grove Village 12
Lappeenranta 12
Orem 12
Verona 12
Amsterdam 11
Charlotte 11
Montreal 11
Shanghai 11
Bologna 10
Catania 10
Fairfield 10
Pune 10
Washington 10
Bari 9
Jacksonville 9
Pesaro 9
Phoenix 9
Poplar 9
San Francisco 9
Tampa 9
Belo Horizonte 8
Biên Hòa 8
Boardman 8
Brescia 8
Da Nang 8
Haiphong 8
Istanbul 8
Toronto 8
Ancona 7
Curitiba 7
Guarulhos 7
Juiz de Fora 7
Pescara 7
Philadelphia 7
Salvador 7
Schiffdorf 7
Vienna 7
Bragança Paulista 6
Guayaquil 6
Madison 6
Miami 6
Modena 6
Munich 6
Nairobi 6
Palermo 6
Pisa 6
Quito 6
San José 6
Albignasego 5
Albuquerque 5
Totale 5.504
Salva come PNG Salva come JPEG
Nome #
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study 714
Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study 502
THE RELATION BETWEEN OBESITY AND PROSTATE CANCER: THE ROLE OF ABDOMINAL OBESITY AND BODY FRAME 400
18F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study 258
Clinical experience with 18F-JK-PSMA-7 when using a digital PET/CT 167
New treatment strategies for benign prostatic hyperplasia in the frail elderly population: A systematic review 114
The grade of systemic inflammation, immune inhibition, and gut dysbiosis as prognostic factors for bladder cancer recurrence: a metabolomics approach 102
Antibodies targeting prostate-specific membrane antigen positive prostate cancer: from diagnostic imaging to theranostics 101
Accuracy of frozen section analysis of urethral and ureteral margins during radical cystectomy for bladder cancer: a systematic review and diagnostic Meta-Analysis 97
Prospective per‐target analysis of the added value of the PrecisionPoint Transperineal Access System in cognitive prostate biopsy of MRI targets 92
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer 92
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding 89
Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review 87
CAR-T cell therapy for solid tumors: are we still that far? A systematic review of literature 84
Sexual dysfunction due to pudendal neuralgia: A systematic review 81
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate 81
Clinical effect of computed guided pudendal nerve block for patients with premature ejaculation: a pilot study 79
Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens 79
Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery 78
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy 78
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic 78
A systematic review of imaging-guided metastasis-directed therapy for oligorecurrent prostate cancer: revolution or devolution? 76
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches 76
Analysis of predictors of early trifecta achievement after robot-assisted radical prostatectomy for trainers and expert surgeons: the learning curve never ends 75
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non–muscle-invasive Bladder Cancer 75
New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives 73
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer 72
Antibody-Drug Conjugates in Prostate Cancer: Where Are we? 71
Management of chronic testicular pain due to thoracolumbar junction syndrome: A pilot study|La prise en charge de la douleur testiculaire chronique due a un syndrome de charniere thoraco-lombaire : étude pilote 70
Restaging transurethral resection in ta high-grade nonmuscle invasive bladder cancer: A systematic review 70
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial) 70
Clinical validation of the intermediate-risk non–muscle-invasive bladder cancer scoring system and substratification model proposed by the International Bladder Cancer Group: A multicenter Young Academic Urologists Urothelial Working Group collaboration 69
Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era 68
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis 67
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of core number and location 67
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort 66
Anterior vs. retzius-sparing robotic assisted radical prostatectomy: can the approach really make a difference? 66
Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Urogynecological Surgery: A Systematic Review 65
Cost-analysis of robot-assisted radical cystectomy in Europe: a cross-country comparison 65
Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment 65
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data 65
A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills? 64
External Validation of a Multiparametric Magnetic Resonance Imaging–based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy 64
Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature 64
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines 64
Laparoscopic treatment of pudendal nerve and artery entrapment improves erectile dysfunction in healthy young males 64
Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses 63
Robot-assisted radical cystectomy: towards a future of sexual-sparing surgery? 63
Prostate cancer, androgen deprivation, and risk of COVID-19 infection: A systematic review and meta-analysis|Cancer de Prostate, déprivation androgénique, et risques d'infection par la COVID-19: revue systématique et méta-analyse 63
Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy 62
68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy 61
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art 60
Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion 59
New Technologies for Kidney Surgery Planning 3D, Impression, Augmented Reality 3D, Reconstruction: Current Realities and Expectations 59
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers 59
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis 58
The train has already left the station: Analyzing the rise of PSMA PET/ CT as new standard for staging high risk prostate cancer 58
Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation 58
Magnetic Resonance Imaging-Targeted Biopsy and Pretherapeutic Prostate Cancer Risk Assessment: a Systematic Review: Biopsie ciblée par Imagerie par résonance magnétique et évaluation pré-thérapeutique du risque de cancer de la prostate : revue systématique 58
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis 58
A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer 57
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis 57
A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy 57
Are Italian urologists and nurses ready for electronic instructions for use? A nationwide survey 57
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study 57
Setting new standards: robot-assisted radical prostatectomy as a day case 57
Prognostic value of PlGF upregulation in prostate cancer 56
Long-term experience with early single Mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: Prospective, single-centre randomised trial 56
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication Index 56
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators 56
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients 54
Reassessment of the efficacy of carboplatin for metastatic urothelial carcinoma in the Era of immunotherapy: a systematic review and meta-analysis 54
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta‐analysis 54
Urinary microbiota and prostatic diseases: the key for the lock? A systematic review 54
Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature 53
Prevalence of lower urinary tract symptoms in taxi drivers: a cross-sectional web-based survey 53
To what extent should we trust statistics? 53
Can the success with immunotherapy in metastatic urothelial bladder carcinoma be replicated in the neoadjuvant setting? 53
Bladder cancer at the time of COVID-19 outbreak 52
Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort 52
Myths, Superstitions, and Popular Beliefs: Do They Still Impact Our Practice? 51
Does antibiotic use explain the discrepancy of urolithiasis prevalence between countries? 51
Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand? 51
Prebiopsy 68Ga-PSMA PET imaging: can we improve the current diagnostic pathway for prostate cancer? 51
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics 51
Contemporary management of benign uretero-enteric strictures after cystectomy: a systematic review 49
Cartography-based quality control of prostate cancer care: A necessary ground to targeted focal therapy 49
COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor|COVID-19 et la susceptibilité du sexe masculin: le rôle de l'ACE2, la TMPRSS2 et le récepteur aux androgènes 49
External validation of models for prediction of side-specific extracapsular extension in prostate cancer patients undergoing radical prostatectomy 48
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications 48
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy 47
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study 47
COVID-19 and BCG: where’s the challenge? 47
Focal therapy for prostate cancer: Making the punishment fit the crime|Thérapie focale pour le cancer de la prostate : une peine correspondante au crime 47
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis 47
Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy 46
Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: A 12 months analysis after three consecutive prostate biopsies 46
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer—An Inventory Roundtable and Literature Review 46
Evidence-based medicine, the number ‘three’ and its multiples in urological clinical rules 45
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis 45
Totale 8.062
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 3 1 2 0 2 1 0 0 2 1 6
2022/2023806 2 1 1 1 2 628 80 5 14 7 44 21
2023/2024518 14 20 31 16 45 195 60 24 32 21 20 40
2024/20252.993 38 372 192 145 132 214 402 361 446 283 218 190
2025/20264.999 417 319 559 258 417 118 489 649 590 502 424 257
2026/202746 46 0 0 0 0 0 0 0 0 0 0 0
Totale 10.101